A Market Cap History
Below is a table of the A market cap history going back to 1/31/2010:

Date A Market Cap
1/31/20109.76B
4/30/201012.62B
7/31/20109.67B
11/30/201012.17B
1/31/201114.44B
4/30/201117.37B
7/31/201114.64B
12/1/201113.17B
1/31/201214.76B
4/30/201214.66B
7/31/201213.34B
1/31/201315.55B
4/30/201314.28B
7/31/201314.80B
1/31/201419.39B
4/30/201418.01B
7/31/201418.71B
12/1/201413.95B
1/31/201512.68B
4/30/201513.78B
8/31/201512.03B
12/1/201513.64B
1/31/201612.34B
4/30/201613.32B
8/31/201615.24B
12/1/201613.90B
2/28/201716.53B
5/31/201719.39B
8/31/201720.83B
12/1/201722.19B
2/28/201822.12B
5/24/201820.52B
8/24/201821.03B
12/10/201822.49B

Also see: A Shares Outstanding History
and A YTD Return
A Historical Market Cap:
+9.88% CAGR
A Historical Market Cap: +9.88% CAGR

Mouse over chart for data details
1/31/2010 ...12/10/2018
Agilent Technologies is engaged in the life sciences, diagnostics and chemical markets. Co. has three business segments: Life Sciences and Applied Markets, which provides solutions including instruments and software to identify, quantify and analyze the physical and biological properties of substances and products, and to interrogate samples at the molecular and celullar level; Diagnostics and Genomics, which includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses; and Agilent CrossLab, which spans the entire lab with its consumables and services portfolio. We show 34 historical shares outstanding datapoints in our A shares outstanding history coverage, used to compute A market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing A market cap history over the course of time is important for investors interested in comparing A's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of A versus a peer is one thing; comparing A market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like A can fluctuate over the course of history. With this page we aim to empower investors researching A by allowing them to research the A market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for A:
A SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Agilent Technologies (A) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AAC Market Cap History
ABAX Market Cap History
ABBV Market Cap History
ABC Market Cap History
ABEO Market Cap History
ABIO Market Cap History
ABMD Market Cap History
ABT Market Cap History
ACAD Market Cap History
ACER Market Cap History
More Healthcare companies »

 

A Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.